Magenta Therapeutics
Latest round
- Series C
Last raised
- Apr 2018
Total raised
- $151M
Investors
- 10
About Magenta Therapeutics
Magenta Therapeutics, Inc. is a US-based biotechnology company focused on developing innovative therapies that harness the power of stem cells to address serious diseases.Founded in 2015, Magenta Therapeutics, Inc. is dedicated to pioneering stem cell-based therapies.Magenta Therapeutics specializes in developing advanced biotechnological solutions, primarily focusing on stem cell therapies aimed at treating various serious diseases. The company's core products are designed to promote efficient patient care through innovative treatments that enhance the healing process. Their offerings have gained traction among healthcare providers and researchers seeking effective solutions in transplant medicine.97 mn.Magenta Therapeutics plans to expand its product lineup with new stem cell therapies that are currently in development, aiming for launches in the upcoming years. The company is also targeting expansion into European and Asian markets by 2025 to increase its global footprint.40 mn will support these initiatives, particularly in advancing clinical trials and product development, enhancing the company's capability to deliver innovative solutions in regenerative medicine.
Who invested in Magenta Therapeutics
10 investors across 3 rounds
See all investors in Magenta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Magenta Therapeutics
Who invested in Magenta Therapeutics?
Magenta Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Magenta Therapeutics raised?
Magenta Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Magenta Therapeutics last raise money?
Magenta Therapeutics's most recent round on record is a Series C, in Apr 2018.
What does Magenta Therapeutics do?
Magenta Therapeutics is a biotechnology company.
Where is Magenta Therapeutics headquartered?
Magenta Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Magenta Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Magenta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Magenta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.